Evidence map›Paper›PMID 15745966›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2005

Cytoprotective effects of geranylgeranylacetone against retinal photooxidative damage.

Masaki Tanito, Yong-Won Kwon, Norihiko Kondo, Jie Bai, Hiroshi Masutani, Hajime Nakamura, Junichi Fujii, Akihiro Ohira, Junji Yodoi

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 90 citations in OpenAlex.

  1. Review
  2. Article
  3. Immunomodulatory and Antioxidant Drugs in Glaucoma Treatment.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  4. Review
  5. Review
  6. Experimental and therapeutic medicine · 2021
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Targeting Oxidative Stress for Treatment of Glaucoma and Optic Neuritis.Oxidative medicine and cellular longevity · 2017
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Masaki TanitoDepartment of Biological Responses, Institute for Virus Research, Kyoto University, Kyoto 606-8507, Japan.
Yong-Won Kwon
Norihiko Kondo
Jie Bai
Hiroshi Masutani
Hajime Nakamura
Junichi Fujii
Akihiro Ohira
Junji Yodoi
Kyoto University · JPKyoto University Hospital · JPShimane University · JPYamagata University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exposure to excessive light induces retinal photoreceptor cell damage, leading to development and progression of various retinal diseases. We tested the effect of geranylgeranylacetone (GGA), an acyclic polyisoprenoid, on light-induced retinal damage in mice. Oral treatment with GGA (1.0 mg/d) for 5 d induced thioredoxin (Trx) and heat shock protein 72 (Hsp72) predominantly in the retinal pigment epithelium (RPE). After white light exposure (8000 lux for 2 h), the percentage of terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling-positive photoreceptor cells decreased significantly at 24 and 96 h, and the number of photoreceptor cell nuclei at 96 h and the electroretinographic amplitudes of the a- and b-waves at 4 and 10 d increased significantly in GGA-pretreated mice compared with saline-pretreated mice. Light-induced upregulations of 8-hydroxy-2-deoxyguanosine and 4-hydroxy-2-nonenal-modified protein, markers of oxidative stress, were inhibited by GGA pretreatment. To elucidate the cytoprotective mechanism of GGA and Trx, we used human K-1034 RPE cells and mouse photoreceptor-derived 661W cells. In K-1034 cells, GGA (10 microM) induced intracellular Trx, Hsp72, and extracellular Trx but not extracellular Hsp72. Extracellular Trx (0.75 nM) attenuated H2O2 (200 microM)-induced cell damage in 661W cells. Pretreatment with GGA and overexpression of Trx in K-1034 cells counteracted H2O2 (50 microM)-induced attenuation of cellular latex bead incorporation. Protection of phagocytotic activity through induction of Trx and possibly Hsp72 in RPE cells and elimination of oxidative stress in the photoreceptor layer through release of Trx from RPE cells may be mechanisms of GGA-mediated cytoprotection. Therefore, Trx is a neurotrophic factor released from RPE cells and plays a crucial role in maintaining photoreceptor cell integrity.

Indexed as

8-Hydroxy-2'-DeoxyguanosineAldehydesAnimalsBlotting, WesternCell CountCell DeathCell LineDeoxyguanosineDisease Models, AnimalDiterpenesElectroretinographyEnzyme-Linked Immunosorbent AssayFlow CytometryGene ExpressionHSP72 Heat-Shock ProteinsHumans4-hydroxy-2-nonenal8-Hydroxy-2'-DeoxyguanosineAldehydesDeoxyguanosineDiterpenesgeranylgeranylacetoneHSP72 Heat-Shock ProteinsHydrogen PeroxideNeoplasm ProteinsNeuroprotective AgentsThioredoxins

Identifiers

PMID15745966
PMCPMC6726103
OpenAlexW2001499242

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.